Bayer believes it is on course for possible approval following positive study data on the active substance elinzanetant for the treatment of certain menopausal symptoms. This non-hormonal treatment.
Bayer believes it is on course for a possible approval following positive study data on the active substance elinzanetant for the treatment of certain menopausal symptoms. This non-hormonal treatment.